{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:58:52Z","timestamp":1791583132941,"version":"4.3.4"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamacardio.2019.1391","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T13:15:34Z","timestamp":1558530934000},"page":"644","source":"Crossref","is-referenced-by-count":307,"title":["Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1001","volume":"4","author":[{"given":"Martin S.","family":"Maron","sequence":"first","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wessler","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Mooney","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Fatima","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Koethe","sequence":"additional","affiliation":[{"name":"Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Romashko","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, University of Texas, Dallas"},{"name":"Southwestern Medical Center, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Maron","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"hoi190022r1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy.","volume":"379","author":"Maron","year":"2018","journal-title":"N Engl J Med"},{"issue":"39","key":"hoi190022r2","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi190022r3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/jamacardio.2015.0354","article-title":"How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice.","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"24","key":"hoi190022r4","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"hoi190022r5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.","volume":"64","author":"Maron","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi190022r6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"hoi190022r7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"9254","key":"hoi190022r8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"hoi190022r9","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.117.032627","article-title":"Predicting the future in hypertrophic cardiomyopathy.","volume":"137","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"hoi190022r10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","article-title":"A validation study of the 2003 American College of Cardiology\/European Society of Cardiology and 2011 American College of Cardiology Foundation\/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.","volume":"99","author":"O\u2019Mahony","year":"2013","journal-title":"Heart"},{"issue":"4","key":"hoi190022r11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/CIRCEP.115.003140","article-title":"Prophylactic implantable defibrillators for hypertrophic cardiomyopathy: disarray in the era of precision medicine.","volume":"8","author":"Grace","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"hoi190022r12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.cjca.2015.07.724","article-title":"A family history of sudden death should not be a primary indication for an implantable cardioverter defibrillator in hypertrophic cardiomyopathy.","volume":"31","author":"Watkinson","year":"2015","journal-title":"Can J Cardiol"},{"issue":"6","key":"hoi190022r13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"hoi190022r14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"hoi190022r15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"3","key":"hoi190022r16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ahj.2013.06.009","article-title":"Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.","volume":"166","author":"Vriesendorp","year":"2013","journal-title":"Am Heart J"},{"issue":"4","key":"hoi190022r17","doi-asserted-by":"publisher","first-page":"e005820","DOI":"10.1161\/CIRCEP.117.005820","article-title":"Clinical course and quality of life in high-risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators.","volume":"11","author":"Maron","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"hoi190022r18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.amjcard.2017.10.027","article-title":"Comparison of the prognostic usefulness of the European Society of Cardiology and American Heart Association\/American College of Cardiology Foundation risk stratification systems for patients with hypertrophic cardiomyopathy.","volume":"121","author":"Leong","year":"2018","journal-title":"Am J Cardiol"},{"issue":"18","key":"hoi190022r19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies.","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi190022r20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies.","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"14","key":"hoi190022r21","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.","volume":"61","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hoi190022r22","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.amjcard.2017.08.048","article-title":"Interaction of adverse disease related pathways in hypertrophic cardiomyopathy.","volume":"120","author":"Rowin","year":"2017","journal-title":"Am J Cardiol"},{"issue":"9","key":"hoi190022r23","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/hrt.2006.090290","article-title":"Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy.","volume":"93","author":"Woo","year":"2007","journal-title":"Heart"},{"issue":"10","key":"hoi190022r24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/pace.2008.31.issue-10","article-title":"Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy.","volume":"31","author":"Kiernan","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"hoi190022r25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.hrthm.2015.12.048","article-title":"Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.","volume":"13","author":"Maron","year":"2016","journal-title":"Heart Rhythm"},{"issue":"9","key":"hoi190022r26","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi190022r27","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"issue":"7","key":"hoi190022r28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management.","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi190022r29","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"issue":"24","key":"hoi190022r30","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"issue":"13","key":"hoi190022r31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy.","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"hoi190022r32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi190022r33","doi-asserted-by":"publisher","first-page":"e004604","DOI":"10.1161\/CIRCEP.116.004604","article-title":"Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy.","volume":"10","author":"Wang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"hoi190022r34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.amjcard.2017.12.044","article-title":"Impact of advanced therapies for improving survival to heart transplant in patients with hypertrophic cardiomyopathy.","volume":"121","author":"Rowin","year":"2018","journal-title":"Am J Cardiol"},{"issue":"5","key":"hoi190022r35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy =60 years of age.","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"hoi190022r36","article-title":"Left\u00a0ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age","author":"Rowin","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"hoi190022r37","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy.","volume":"33","author":"Olivotto","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"hoi190022r38","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy.","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"hoi190022r39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"issue":"30","key":"hoi190022r40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"issue":"15","key":"hoi190022r42","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"hoi190022r43","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"International external validation study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).","volume":"137","author":"O\u2019Mahony","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"hoi190022r44","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCEP.114.002553","article-title":"Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.","volume":"8","author":"Vriesendorp","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"hoi190022r45","first-page":"1728","article-title":"Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge.","volume":"38","author":"Weissler-Snir","year":"2017","journal-title":"Eur Heart J"},{"issue":"9","key":"hoi190022r46","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors.","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"issue":"29","key":"hoi190022r47","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation.","volume":"35","author":"Steyerberg","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"hoi190022r48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy.","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"},{"issue":"6","key":"hoi190022r49","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1161\/CIRCULATIONAHA.118.038436","article-title":"Evaluating and reducing the risk of sudden death in hypertrophic cardiomyopathy.","volume":"139","author":"Udelson","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"hoi190022r50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrcardio.2017.6","article-title":"Shared decision-making in HCM.","volume":"14","author":"Maron","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"hoi190022r51","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jacc.2017.02.017","article-title":"The proliferation of scoring systems: trying to keep our heads out of the clouds.","volume":"69","author":"Fuster","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi190022r52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamacardio.2018.1423","article-title":"Is the cognitive cardiologist obsolete?","volume":"3","author":"Brush","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"hoi190022r53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi190022r54","doi-asserted-by":"publisher","first-page":"e63911","DOI":"10.1371\/journal.pone.0063911","article-title":"Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.","volume":"8","author":"Streitner","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"hoi190022r55","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.","volume":"110","author":"Moss","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"hoi190022r56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jamacardio.2016.1113","article-title":"Saving lives one at a time.","volume":"1","author":"Maron","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"8","key":"hoi190022r57","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.amjcard.2005.11.048","article-title":"Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?","volume":"97","author":"Germano","year":"2006","journal-title":"Am J Cardiol"},{"issue":"24","key":"hoi190022r58","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.117.027738","article-title":"Perspectives on the overall risks of living with hypertrophic cardiomyopathy.","volume":"135","author":"Maron","year":"2017","journal-title":"Circulation"},{"key":"hoi190022r41","unstructured":"AriasE, HeronM, XuJ. United States Life Tables, 2014. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr66\/nvsr66_04.pdf. Accessed November 19, 2018."}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamacardiology\/article-pdf\/4\/7\/644\/17729255\/jamacardiology_maron_2019_oi_190022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T11:03:04Z","timestamp":1563361384000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2019.1391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.1391","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}